Murali has been an integral part of Aurigene since February 2005. Before assuming the role of CEO, he served as Chief Scientific Officer at Aurigene. His extensive experience in leading successful and innovative R&D at both operational and strategic levels was instrumental in establishing a robust pipeline of clinical and pre-clinical assets. Prior to Aurigene, Murali held positions of increasing responsibility at the National Institute of Health, USA, and Schering-Plough, USA, contributing significantly to various aspects of drug discovery. He earned his PhD from the University of Idaho, USA, and completed his Postdoctoral fellowship at DuPont Experimental Station and the University of Kansas Medical Centre, Kansas City, USA. Murali has co-authored over 75 scientific publications in peer-reviewed journals, and an inventor of 30 granted US patents.